<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55067">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02389257</url>
  </required_header>
  <id_info>
    <org_study_id>MINIMAG</org_study_id>
    <nct_id>NCT02389257</nct_id>
  </id_info>
  <brief_title>Optically Pumped 4He Magnetometers Performances Compared With Medical Reference Methods (ECG and MEG)</brief_title>
  <acronym>MINIMAG</acronym>
  <official_title>Optically Pumped 4He Magnetometers Performances Compared With Medical Reference Methods : Electrocardiography (ECG) and Magnetoencephalography (MEG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optically Pumped 4He Magnetometers operability for cerebral and cardiac magnetic fields
      measurement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optically Pumped 4He Magnetometers vs reference sensors electrocardiogram (ECG) or SQUIDs
      data acquisitions
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with Adverse EventsMagnetic brain or cardiac activity</measure>
    <time_frame>1 year</time_frame>
    <description>Measure of Safety and Tolerability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brain or cardiac magnetic activity (Cerebral or cardiac magnetic fields record)</measure>
    <time_frame>1 hour</time_frame>
    <description>Cerebral or cardiac magnetic fields record</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>MINIMAG / MEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cerebral magnetic fields</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MINIMAG / ECG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cardiac magnetic fields</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MINIMAG / MEG</intervention_name>
    <arm_group_label>MINIMAG / MEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MINIMAG / ECG</intervention_name>
    <arm_group_label>MINIMAG / ECG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  more or equal than 18 years old

          -  patient affiliated to social security or similarly regime

          -  informed consent form signed

          -  without cardiac, neurologic, psychiatric or metabolic medical history.

        Exclusion Criteria:

          -  Pregnant women and lactating mothers

          -  Ward of court or under guardianship

          -  Adult unable to express their consent

          -  Person deprived of freedom by judicial or administrative decision

          -  Person hospitalized without their consent

          -  Person under legal protection

          -  Person with any implant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>François BERGER, MD, PhD</last_name>
    <phone>+ 33 4 38 78 15 18</phone>
    <email>francois.berger@cea.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline SANDRE-BALLESTER, PhD</last_name>
    <phone>+ 33 4 38 78 28 51</phone>
    <email>csandreballester@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CLINATEC</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François BERGER, MD,PhD</last_name>
      <phone>+ 33 4 38 78 15 18</phone>
      <email>francois.berger@cea.fr</email>
    </contact>
    <contact_backup>
      <last_name>Caroline SANDRE-BALLESTER, PhD</last_name>
      <phone>+ 33 4 38 78 28 51</phone>
      <email>csandreballester@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 24, 2016</lastchanged_date>
  <firstreceived_date>January 8, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>volunteers</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
